ONWARD Medical Private Placement · $55M raised

ONWARD Medical is a NeuroTech company focused on developing and commercializing breakthrough technologies that restore movement, function, and independence in people with spinal cord injuries and other movement disabilities. Their proprietary ARC Therapy targets spinal cord stimulation. The company offers both external (ARC-EX® System) and investigational implantable (ARC-IM®) devices. The ARC-EX® System is approved for commercial sale in the US and Europe. The ARC-IM® system is being evaluated in clinical trials for addressing unmet needs like blood pressure instability and can be combined with brain-computer interfaces (BCI) and AI for thought-driven movement.